EXAS vs VSTD · rev $2.76B vs rev $12.8M
EXACT Sciences Corporation (EXAS) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
EXAS currently screens at market cap $20.03B. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the EXAS and VSTD stock pages for the full models.
Not investment advice.